Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois.
Department of Orthopaedic Surgery, Wright State University, Dayton, Ohio, USA.
World Neurosurg. 2022 Feb;158:e717-e725. doi: 10.1016/j.wneu.2021.11.041. Epub 2021 Nov 16.
We sought to assess differences in patient-reported outcome measures (PROMs) between patients who do and do not follow up for 2 years after lumbar fusion.
Primary, elective, single-level anterior lumbar interbody fusion, lateral lumbar interbody fusion, or transforaminal lumbar interbody fusion procedures were identified. Patients were grouped by 2-year PROM follow-up completion. Mean and delta PROM scores for visual analog scale (VAS) back and leg, Oswestry Disability Index (ODI), short-form (SF)-12 Physical Composite Score (PCS), and Mental Composite Score (MCS) were computed for both groups preoperatively and postoperatively. Minimum clinically important difference (MCID) achievement was determined for PROM scores using established threshold values. Linear and logistic regression assessed mean and ΔPROM scores as predictors of 2-year follow-up completion and compared MCID achievement between groups, respectively.
We included 316 lumbar fusion patients. PROM scores were more favorable for complete follow-up patients for 6-month VAS back (P = 0.003), 6-month and 1-year ODI (P ≤ 0.027, both), and 6-week and 6-month SF-12 PCS (P ≤ 0.015, both). Six-month VAS back (P = 0.007); 6-month and 1-year ODI (P ≤ 0.028, both); 6-week, 6-month, and 1-year SF-12 PCS (P ≤ 0.041, all); and 6-week SF-12 MCS (P ≤ 0.028, both) significantly predicted 2-year follow-up. ΔPROMs significantly differed between groups at 1 year for ΔVAS leg (P = 0.029), ΔODI (P = 0.013), and ΔSF-12 MCS (P = 0.004). One-year ΔVAS leg (P = 0.035), ΔODI (P = 0.011), and ΔSF-12 MCS (P = 0.003) significantly predicted follow-up. MCID achievement for ΔPROMs significantly differed between groups for 6-week VAS leg (P = 0.035), overall ODI (P = 0.034), and SF-12 PCS from 12 weeks through 1 year (P ≤ 0.011, all) and overall (P < 0.001).
Patients with full follow-up demonstrated significantly more favorable outcome scores and improvement in pain, disability, and physical function at several postoperative time points.
我们旨在评估腰椎融合术后 2 年随访的患者和未随访的患者在患者报告的结局测量(PROM)方面的差异。
确定了原发性、选择性、单节段前路腰椎间融合术、侧路腰椎间融合术或经椎间孔腰椎间融合术。根据 2 年 PROM 随访完成情况将患者分为两组。计算两组患者术前和术后视觉模拟量表(VAS)背部和腿部、Oswestry 残疾指数(ODI)、简明健康调查问卷(SF)-12 物理综合评分(PCS)和精神综合评分(MCS)的平均和 delta PROM 评分。使用既定阈值确定 PROM 评分的最小临床重要差异(MCID)的实现。线性和逻辑回归评估了平均和 ΔPROM 评分作为 2 年随访完成的预测指标,并分别比较了两组之间的 MCID 实现情况。
我们纳入了 316 例腰椎融合患者。对于完全随访的患者,6 个月 VAS 背部(P = 0.003)、6 个月和 1 年 ODI(P ≤ 0.027,均)和 6 周和 6 个月 SF-12 PCS(P ≤ 0.015,均)的 PROM 评分更有利。6 个月 VAS 背部(P = 0.007);6 个月和 1 年 ODI(P ≤ 0.028,均);6 周、6 个月和 1 年 SF-12 PCS(P ≤ 0.041,均);6 周 SF-12 MCS(P ≤ 0.028,均)显著预测 2 年随访。1 年时,两组间 ΔPROMs 在 ΔVAS 腿部(P = 0.029)、ΔODI(P = 0.013)和 ΔSF-12 MCS(P = 0.004)方面存在显著差异。1 年时 ΔVAS 腿部(P = 0.035)、ΔODI(P = 0.011)和 ΔSF-12 MCS(P = 0.003)显著预测随访。6 周 VAS 腿部(P = 0.035)、总体 ODI(P = 0.034)和 SF-12 PCS 从 12 周至 1 年(P ≤ 0.011,均)和总体(P < 0.001)的 ΔPROMs 中,组间 MCID 实现情况存在显著差异。
完全随访的患者在术后多个时间点的疼痛、残疾和身体功能方面表现出显著更有利的结局评分和改善。